|
Volumn 41, Issue 3, 2001, Pages 285-289
|
Prevalence of migraine in patients with systemic lupus erythematosus
a a b b a |
Author keywords
Antiphospholipid antibodies; Migraine; Raynaud; Systemic lupus erythematosus
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMITRIPTYLINE;
ANTIMALARIAL AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
FUROSEMIDE;
HYDROXYCHLOROQUINE;
IBUPROFEN;
IMMUNOSUPPRESSIVE AGENT;
INDOMETACIN;
LORAZEPAM;
METHOTREXATE;
METHYLPREDNISOLONE;
NAPROXEN;
NIFEDIPINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHOLIPID ANTIBODY;
PREDNISONE;
VALPROIC ACID;
ADULT;
AGED;
ARTICLE;
CLINICAL FEATURE;
DISABILITY;
DISEASE CLASSIFICATION;
EPILEPTIC AURA;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MIGRAINE;
PREVALENCE;
PRIORITY JOURNAL;
RAYNAUD PHENOMENON;
SEROLOGY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
BOSTON;
FEMALE;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
PREVALENCE;
QUESTIONNAIRES;
|
EID: 0035087564
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2001.111006285.x Document Type: Article |
Times cited : (56)
|
References (6)
|